Impact of sacubitril/valsartan on implantable defibrillator eligibility in heart failure: a real-world experience

被引：0
|
作者：
Monzo, L. [1 ]
Cicogna, F. [2 ]
Tota, C. [2 ]
Petronilli, V. [2 ]
Mennuni, S. [2 ]
De Ruvo, E. [2 ]
Calo, L. [2 ]
机构：
[1] Sapienza Univ Rome, Dept Clin Internal Anesthesiol & Cardiovasc Sci, Rome, Italy
[2] Polyclin Casilino Rome, Dept Cardiol, Rome, Italy
来源：
EUROPEAN JOURNAL OF HEART FAILURE | 2021年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：42 / 43
页数：2
相关论文
共 50 条
  • [1] Impact of sacubitril/valsartan on implantable defibrillator eligibility in heart failure: a real-world experience
    Monzo, L.
    Gaudio, C.
    Cicogna, F.
    Tota, C.
    Petronilli, V
    Mennuni, S.
    De Ruvo, E.
    Calo, L.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2021, 25 (18) : 5690 - 5700
  • [2] Impact of sacubitril/valsartan on implantable defibrillator eligibility in heart failure: a real-world experience
    Monzo, Luca
    Ferrari, Ilaria
    Gaudio, Carlo
    Cicogna, Francesco
    Tota, Claudia
    Petronilli, Valentina
    Mennuni, Silvia
    Ruvo, Ermenegildo De
    Calo, Leonardo
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2021, 23 (SUPPL G)
  • [3] Impact of sacubitril/valsartan on implantable defibrillator eligibility in heart failure: a real-world experience
    Monzo, Luca
    Ferrari, Ilaria
    Gaudio, Carlo
    Cicogna, Francesco
    Tota, Claudia
    Petronilli, Valentina
    Mennuni, Silvia
    De Ruvo, Ermenegildo
    Calo, Leonardo
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2021, 23 (0G)
  • [4] Impact of sacubitril/valsartan on implantable defibrillator eligibility in heart failure: a real-world experience (vol 25, pg 5690, 2021)
    Monzo, L.
    Gaudio, C.
    Cicogna, F.
    Tota, C.
    Petronilli, V.
    Mennuni, S.
    De Ruvo, E.
    Calo, L.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2022, 26 (07) : 2216 - 2216
  • [5] Real world experience with sacubitril/valsartan in heart failure
    Lim, E. L. S.
    Abdullah, E. L.
    Loh, L. C. W.
    Chong, P. F.
    Sia, H. P.
    Sothivadivel, S.
    Lee, J. L.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2024, 417
  • [6] REAL-WORLD IMPACT OF SACUBITRIL/VALSARTAN ON THE QUALITY OF LIFE OF HEART FAILURE PATIENTS IN PORTUGAL
    Afonso Nogueira, M.
    Afonso-Silva, M.
    Gomes, M.
    Andreozzi, V
    Vandewalle, B.
    Costa Ferreira, F.
    Monica, L.
    Cruz, L.
    Guimaraes, M.
    Proenca, G.
    VALUE IN HEALTH, 2020, 23 : S504 - S505
  • [7] Eligibility criteria for Sacubitril-Valsartan in patients admitted for heart failure: the real world
    David Cabrita Roque, D.
    Augusto, J.
    Santos, M.
    Candeias Faria, D.
    Baltazar Ferreira, J.
    Sacchetti, A.
    Melo, L.
    Oliveira Soares, A.
    Morais, C.
    EUROPEAN JOURNAL OF HEART FAILURE, 2018, 20 : 477 - 478
  • [8] The benefits of sacubitril/valsartan in the treatment of patients with heart failure: a real-world, single centre experience
    Celli, Valdisa
    Tari, Ylenia
    Ansani, Katia
    Bernardini, Livio
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2020, 22 (0N) : N90 - N90
  • [9] Eligibility for sacubitril/valsartan in heart failure across the ejection fraction spectrum: real-world data from the Swedish Heart Failure Registry
    Savarese, G.
    Hage, C.
    Benson, L.
    Schrage, B.
    Thorvaldsen, T.
    Lundberg, A.
    Fudim, M.
    Linde, C.
    Dahlstrom, U.
    Rosano, G. M. C.
    Lund, L. H.
    JOURNAL OF INTERNAL MEDICINE, 2021, 289 (03) : 369 - 384
  • [10] Impact of sacubitril/valsartan on heart failure admissions: insights from real-world patient prescriptions
    Martens, Pieter
    Lambeets, Seppe
    Lau, Chirik Wah
    Dupont, Matthias
    Mullens, Wilfried
    ACTA CARDIOLOGICA, 2019, 74 (02) : 115 - 122
12345